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Abstract 
Akabane virus (AKAV), an arthropod‑transmitted bunyavirus, is a major cause of congenital abnormalities and enceph‑
alomyelitis in ruminants. In 2010, there was a major outbreak of encephalomyelitis in Korea and fifteen AKAV strains, 
including AKAV‑7, were isolated from cows. To identify the neuropathogenicity of AKAV‑7, we performed experi‑
mental infection of cows. Six‑month‑old female Korean Holstein dairy cattle were inoculated with AKAV‑7 by various 
routes, including intracerebral (IC), intrasubarachnoid space (IS), subcutaneous (SC) and intravenous (IV); a separate 
group was vaccinated before intravenous infection. Five of the six cows in the IC group and two of the six cows in 
the IS group showed clinical signs such as locomotor ataxia and paralysis of the hind limbs. Three of six cows died 
after IC infection 9–12 days post infection (dpi). Histopathologic changes such as nonsuppurative encephalomyelitis 
were confirmed in various parts of the central nervous system in the IC, IS and SC groups. Early onset of neutralizing 
antibodies in the serum and lower viral mRNA levels in the peripheral blood mononuclear cells (PBMCs) and various 
tissues in the vaccinated group was noticeable compared to the unvaccinated group (IV group). We suggest that the 
AKAV vaccine currently used in Korea may be partially effective for protection against AKAV‑7 in cows.
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provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Introduction
Akabane virus (AKAV), a member of the Orthobunyavi-
rus genus in the family Bunyaviridae, is transmitted by 
an arthropod vector such as Culicoides biting midges. 
This arthropod-borne virus (arbovirus) circulates widely 
in the tropical and temperate zones of the world [1–4]. 
It is distributed throughout Southeast Asia, East Asia, 
Australia and the Middle East [5]. Akabane disease is 
an AKAV related disease of ruminants causing congeni-
tal abnormalities including abortions, premature births, 
stillbirths and congenital malformations such as arthro-
gryposis-hydranencephaly syndrome [6].
Similar to other members of the genus Orthobunya-
virus, AKAV has a lipid envelope and a genome that 
forms three segments of single-stranded negative-sense 
RNA, referred to as S (small), M (medium) and L (large) 
depending on their size [7]. With phylogenetic analysis, 
AKAV can be classified into four distinct genogroups (I–
IV) and genogroup I is subdivided into two subgroups (Ia 
and Ib) [6, 8, 9].
In Japan, the prototype AKAV strain was first isolated 
from mosquitoes in 1959 [10]. Sporadic outbreaks of 
Akabane disease have been reported in many other coun-
tries [11–13]. In Korea, the first outbreak of Akabane dis-
ease was reported in 1980 [14]. The main clinical signs 
of Akabane disease are congenital abnormalities in the 
fetus; however, the AKAV variant strain Iriki was isolated 
from 10 calves in Japan with neurological signs and non-
suppurative encephalitis in 1984 and caused encephalitis 
in calves by experimental inoculation [15]. Since then, 
additional AKAV strains also caused encephalomyelitis 
of calves and adult cows in Taiwan [4]. In 2000, encepha-
lomyelitis associated with AKAV infection in cows was 
also reported in Korea [16].
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From late summer to late autumn 2010, a major out-
break of Akabane viral encephalomyelitis in adult cows 
occurred in the southern part of Korea. More than 500 
cattle showed primarily neurological signs such as loco-
motor ataxia, astasia, tremors, hypersensitivity and 
paralysis of the fore- or hind limbs. Nonsuppurative 
encephalomyelitis manifesting mainly as lymphohistio-
cytic perivascular cuffing, gliosis and neuronal degen-
eration was observed in the brain and spinal cord of 
infected cows on histopathologic examination [17]. The 
fifteen strains of AKAV containing AKAV-7/SKR/2010 
(AKAV-7) isolated from the affected cows were classified 
into genogroup Ia within the Iriki strain [18]. In previ-
ous studies, considerable diversity in the antigenic prop-
erties and virulence was observed among field isolates 
of AKAV [15, 19–21]. However, little has been investi-
gated regarding the neuropathogenicity of AKAV strains 
causing nonsuppurative encephalomyelitis in cows. 
Moreover, AKAV genogroup II strains are being used as 
vaccines in Korea [18]. Hence an efficacy assessment of 
a current vaccine for the newly isolated AKAV is nec-
essary. Therefore the aim of this study was to verify the 
neuropathogenicity of AKAV-7 causing encephalomy-




Six-month-old female Korean Holstein dairy cattle were 
used for this experiment. The AKAV antibody titers of 
all cows were seronegative by the virus neutralization 
test (VNT) before experimental procedures. All cows 
were clinically healthy and kept in the animal facility 
at a college of veterinary medicine, Chonbuk National 
University, under standard conditions prescribed by the 
Institutional Guidelines. This experiment was approved 
by the Institutional Animal Care and Use Committee 
(IACUC) of Chonbuk National University.
Virus
The twice-passaged AKAV-7 was provided by the Viral 
Disease Diagnostic Laboratory of Animal Disease Diag-
nostic Division, Animal and Plant Quarantine Agency, 
Republic of Korea. BHK-21 cells were used to grow the 
virus. After removal of cell debris by 15 min of ultracen-
trifugation at 9000  rpm, the 250  mL culture medium, 
including the virus, was concentrated to a 10  mL final 
volume by Vivacell 250 (Sartorius Stedim Biotech, Goe-
ttingen, Germany) to increase the virus titer. Virus 
titer was referred to as the tissue culture infective dose 
(TCID50) and was based on endpoint titration assay. The 
final virus titer was 106.866 TCID50/mL. All protocols 
were performed at 4 °C.
Virus inoculation procedure and sample collection
Animals were divided into intracerebral (IC), intrasuba-
rachnoid (IS), subcutaneous (SC), intravenous (IV), vacci-
nated before intravenous inoculation, and negative control 
groups. A mixture of tiletamine/zolazepam (80  mg/kg of 
body weight, Zoletil; Virbac SA, Carros, France) and xyla-
zine (50 mg/kg of body weight, Rompun; Bayer Healthcare, 
Seoul, Korea) was used to anesthetize cows by intramuscu-
lar injection. For IC inoculation, the right side of the skull 
was trepanned to a depth of approximately 5  mm. One 
milliliter inoculum was injected into the frontal lobe. For 
IS inoculation, 5  mL inoculum was inoculated into the 
subarachnoid space at the level of the thoracolumbar part. 
The SC group was inoculated with 5 mL of inoculum sub-
cutaneously through the skin near the back of the neck. 
For the IV group, 5  mL inoculum was injected through 
the jugular vein. In the vaccinated group, cows were vac-
cinated with a live vaccine (Akabane Cattle Vac, Daesung, 
Korea) intramuscularly and inoculated intravenously with 
5 mL inoculum 3 weeks after vaccination. After infection, 
cows were observed daily to monitor clinical condition. 
Blood samples were collected every 2 days after inocula-
tion to check for viremia and serology. Because peripheral 
blood mononuclear cells (PBMCs) having viral antigen can 
possibly cross blood–brain barrier and induce encepha-
litis, PBMCs were isolated by Histopaque-1077 (Sigma, 
Dorset, UK) and used for viral antigen detection using 
RT-PCR. The cows were sacrificed under deep anesthesia 
7 days post-infection (dpi) in the IC and IS group and 21 
dpi in the IS, SC, IV and vaccinated groups. After sacri-
fice, tissue samples from the brain, spinal cord, spleen and 
lymph nodes were collected.
Viral neutralizing antibody test (VNT)
The collected sera were first heat-inactivated at 56 °C for 
30 min. MDBK cells were raised in alpha-minimum essen-
tial medium (α-MEM; HyClone, Logan, USA) containing 
5% fetal bovine serum and antimycotic antibiotics (Wel-
gene, Daegu, Korea). Flat-bottomed 96-well tissue culture 
plates were used. Briefly, two-fold serial dilutions of the 
serum sample (50 μL) were mixed with equal volume of 
virus containing 200 TCID50/0.1 mL and inoculated with 
MDBK cells. Microscopic examination was conducted on 
the plates after 3 or 5 days for evidence of virus-specific 
cytopathic effects (CPE). Antibody titers were expressed 
as the reciprocal of the highest serum dilution at which 
the CPE were inhibited. A serum dilution titer of 2 (log2) 
or greater was considered seropositive.
Competitive enzyme‑linked immunosorbent assay 
(C‑ELISA)
The AKAV-specific antibodies in the serum were 
detected using the ID Screen® Akabane C-ELISA kit 
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(IDvet Innovative Diagnostics, Montpellier, France), 
as recommended by the manufacturer. The inhibition 
of monoclonal antibody binding after incubation of the 
antigen with each test serum was calculated as the per-
cent inhibition of the monoclonal antibody with respect 
to the reference negative control serum by using the fol-
lowing formula: percent inhibition (PI)  =  100 − [(test 
serum OD)/(mean negative control OD) × 100]. The test 
serum sample was considered to be antibody-positive if 
the PI was ≥70%.
Quantitative real‑time polymerase chain reaction 
(real‑time PCR)
Total viral RNA was isolated from PBMCs and tissue 
using the Easy-Spin Total RNA extraction kit (GeneAll, 
Seoul, Korea). Following incubation with RNase-free 
DNase I (Promega, Madison, WI), reverse transcrip-
tion was performed using a random primer and Multi-
ScribeTM MuLV reverse transcriptase (Thermo Fisher 
Scientific, Waltham, MA, USA) following the manufac-
turer’s instructions. cDNA was subjected to real-time 
PCR on a CFX96 Real-Time PCR Detection SystemTM 
(Bio-Rad Laboratories, Hercules, CA, USA) using SYBR 
Green I dye. PCR amplifications were performed with 
primers in a total volume of 15  μL containing 0.3  μL 
of each primer (Table  1), 7.5  μL of SYBR Green I dye 
(Takara Bio Inc.), and nuclease-free PCR-grade water 
after initial denaturation at 95 °C for 10 min and 50 cycles 
(95 °C for 10 min and 60.5 °C for 30 min). After the reac-
tion was completed, specificity was verified by melting 
curve analysis. Quantification was confirmed by compar-
ing Ct values of each sample with normalization to glyc-
eraldehyde-3-phosphate dehydrogenase (GAPDH).
Histopathologic examination
The tissues were fixed in 10% phosphate-buffered forma-
lin, routinely processed and then embedded in paraffin. 
Tissue Sections (6 μm) were prepared using a microtome 
(HM-340E, Thermo Fisher Scientific, MA, USA), placed 
on a glass slide and stained with haematoxylin and eosin 
(H&E). H&E staining was performed following stand-
ard procedures. With 6  μm-thick paraffin sections, his-
topathological examination in the frontal, parietal and 
occipital lobes of the cerebrum, the cerebellum, brain 
stem (mid brain, pons and medulla oblongata) and spinal 
cord (cervical, thoracic and lumbar) was performed.
Immunohistochemical evaluation
For immunohistochemical staining, the prepared 
6  μm-thick tissue on glass slides was deparaffinized, 
rehydrated, and then immersed in an antigen retrieval 
solution (Dako, Seoul, Korea) for 30 min at 100 °C. A 3% 
peroxidase solution followed by 10% normal goat serum 
was used for blocking. The ImmPACT DAB peroxidase 
substrate kit (Vector Laboratories, Burlingame, CA, 
USA) was used for immunostaining. Rabbit antiserum 
against the 93FMX strain isolated in Korea (reference 
strain in Korea) was used as the primary antibody. The 
antiserum was diluted 1 in 1000 and was incubated with 
the tissue sections for 3 h at room temperature. The anti-
mouse/rabbit immunoglobulin G (ImmPress Universal 
Reagent, Vector Laboratories, Burlingame, CA, USA) was 
used as the secondary antibody and peroxidase substrate 
solution was used until desired stain intensity develops. 
Finally, the sections were counterstained with hematoxy-
lin and processed for mounting with mounting medium.
Statistical analysis
Some data are expressed as mean  ±  SEM. Differences 
between the two groups were compared using a two-
tailed Student’s t test. A value of p < 0.05 was considered 
a statistically significant difference between groups.
Results
Mortality and clinical features of cows
After AKAV-7 injection, all cows were daily observed 
to identify clinical signs. Five of the six cows with neu-
rologic signs such as ataxia, astasia and paralysis of the 
fore- and hind limbs were from the IC inoculation group, 
with symptoms starting 5 and 6 dpi. Two of three cows 
died at 9 dpi, and one of three cows died at 12 dpi after 
IC inoculation. After IS injection, two of six cows showed 
astasia, ataxia, and paralysis of the hind limbs; however, 
these cows survived until sacrifice at 7 and 21 dpi, respec-
tively. In the IV and SC injection groups, there were no 
clinical signs during the experimental periods.
Serological surveys by VNT and C‑ELISA
As shown in Figure 1A, the VNT titers (log2) of only two 
serum samples from one cow were positive at 2 and 6 dpi 
in the IC group. In contrast, 11 of 36 serum samples from 
the IS inoculation group were seropositive. The titers 
started to increase at 4 dpi and steadily maintained in the 
range of 2–6 (log2) at 14 dpi. At 12 dpi, all cows in the 
IS group had positive neutralizing antibodies. After IV 
injection, all cows were seropositive at 8 dpi. The titers 
Table 1 Primer sequences of real-time PCR
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Figure 1 Detection of neutralizing antibodies and specific antibodies against AKAV in the serum of inoculated cows using VNT and 
C-ELISA. A In VNT, animals were considered seropositive when the neutralizing antibody titer (log2) rose above a threshold of 2 (reference line). B In 
C‑ELISA results, P.I. values greater than 70% were considered seropositive (reference line).
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(log2) of the IV group started to increase at 8 dpi and 
appeared in the range of 6–9 at 14 dpi. The highest titer 
in the IV group was 10 at 12 dpi. In the SC inoculation 
group, all cows had positive neutralizing antibodies at 
10 dpi. The titers (log2) were 2 at 6 and 8 dpi and ranged 
from 6–7 at 14 dpi. The highest titer in the SC group was 
7 at 12 and 14 dpi.
In the C-ELISA test, only one cow in the IC group had a 
seropositive titer (>70 titer, PI) 12 dpi because most cows 
died 9 dpi. After IS inoculation, one of six cows appeared 
seropositive 6 dpi and all cows in the 21 dpi group were 
seropositive 12 dpi. In the IV group, two of three cows 
started to show seropositivity 8 dpi and the mean ELISA 
titer rose to 81.4% at 14 dpi. The highest titer in the IV 
group was 91.7% at 12 dpi. After SC inoculation, one of 
three cows was seropositive 6 dpi and all cows had sero-
positive titers from 10 dpi. The titers increased steadily 
until 14 dpi, and the highest titer was 90.7% at 14 dpi in 
the SC group (Figure 1B).
Results of serum surveys revealed a positive correlation 
between VNT and C-ELISA in the IC, IS, IV and SC injec-
tion groups. The correlation rates for VNT and C-ELISA 
were 80.6% (25/31) in the IC group, 91.6% (33/36) in the 
IS group, 83.3% (20/24) in the IV group and 95.8% (23/24) 
in the SC group, respectively (data not shown). All anti-
body results indicated that antibody production levels 
were lower in the IC group compared to others.
Viremia and distribution of AKAV antigens in various 
tissues
After IC injection, two viral load peaks were observed 
in PBMCs 4 and 8 dpi. Viremia was observed as a peak 
after IS injection 4 dpi and decreased after 6 dpi. After IV 
injection, peak viremia was seen in one cow 2 dpi. Viral 
antigen in PBMCs started to decline after 4 dpi. Two 
viremia peaks were detected in PBMCs 6 or 8 dpi and 12 
dpi after SC injection (Figure 2).
After IC inoculation, viral RNA was primarily detected 
in the parietal cerebrum, brain stem and cervical spinal 
cord 7 and 21 dpi. In the IS group, at 7 dpi, viral RNA 
was measured mostly in the spleen, lymph nodes and 
injection region (thoracolumbar part). Similar results 
were found 21 dpi in the IS group, except in the organs 
of the immune system. In the IV group, the detection of 
viral antigen was limited to the spleen. Viral antigen was 
observed mildly or not determined in other tissues. Viral 
RNA was identified markedly in the brain stem and cer-
vical spinal cord after SC inoculation (Figure 3).
Viremia in PBMC











































































































































Figure 2 Detection of AKAV antigen in PBMCs using quantitative real-time PCR to identify viremia. A Results of relative quantification 
in real‑time PCR for detecting AKAV antigen in PBMCs from six cows of the IC group. In the 21 dpi planned group, two of three cows died 9 dpi and 
one of three cows died 12 dpi. B Results from six cows of the IS group, C from three cows of the IV group and D from three cows of the SC group.
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Histopathological lesions and immunohistochemical 
characteristics for AKAV antigens in cows
Histopathologically, nonsuppurative encephalomyelitis 
was characterized by perivascular cuffing (PVC) of lym-
phocytes and macrophages, meningitis with numerous 
lymphocytes and glial nodules consisting of microglial 
cells (gliosis) in the central nervous system (CNS).
After IC inoculation, nonsuppurative encephalomy-
elitis was observed in the cerebrum from all cows at 7 
dpi and one of three cows in the 21 dpi planned group 
(Figures 4A and B). Two of three cows had pathological 
lesions in the cerebellum 7 dpi. In the brain stem, patho-
logical lesions were identified from two of three cows 7 
dpi and two of three cows in the 21 dpi planned group. 
One of three cows showed PVC in the cervical spinal 
cord 7 dpi (Figure  4D). In the IS group, lesions were 
observed in the brain stem and lumbar spinal cord from 
one of three cows 21 dpi (Figures  4E  and F). However 






































































































































































































































































































































































































































































































































































Figure 3 Detection of AKAV antigen in the cerebrum, cerebellum, brain stem, spinal cord and organs of the immune system using 
quantitative real-time PCR. A Results of relative quantification in real‑time PCR for detecting AKAV antigen in various tissues from three cows of 
the IC group 7 and 21 dpi respectively, B from three cows of the IS group 7 and 21 dpi respectively, C from three cows of the IV group 21 dpi and D 
from three cows of the SC group 21 dpi.
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After IV inoculation, there were no pathological 
changes in the CNS. Otherwise, two of three cows in 
the SC group had encephalomyelitis, mainly in the brain 
stem and also in the parietal lobe of the cerebrum and 
cervical spinal cord (Figures  4G  and H). A summary of 
these results is shown in Table 2. None of these changes 
were shown in the CNS of the control group.
Immunohistochemistry (IHC) was performed to detect 
AKAV antigens in the neurons and nerve axons. In the 
IC group, positive viral antigens of the neuron were 
observed predominantly in the frontal and parietal lobe 
of the cerebrum and brain stem 7 and 21 dpi (Figure 5). 
Virus antigens were observed in the pons 21 dpi after SC 
inoculation (Figures  5E and F).
Efficacy assessment of AKAV vaccine against AKAV‑7 
intravenous infection
To evaluate the effect of the AKAV vaccine currently 
used in Korea on AKAV-7 infection, VNT, C-ELISA and 
real-time PCR in the unvaccinated group (IV group) and 
vaccinated group was performed.
At 6 dpi, the viral neutralization antibody titers (log2) of 
the vaccinated group were significantly higher than those 
of the unvaccinated group in VNT (p < 0.001). In addition, 
the mean antibody titer (log2) of the unvaccinated group 
was seronegative [<2 titer, (log2)] at 6 dpi (Figure 6A).
In C-ELISA, the mean antibody titers of the vaccinated 
group were seropositive (>70 titer, PI) 6 dpi. Moreover, 
the viral antibody titers of the vaccinated group were sig-
nificantly higher than those of the unvaccinated group 4 
dpi (p < 0.05) and 6 dpi (p < 0.01) (Figure 6B). The viral 
antibody titers of the unvaccinated group were seronega-
tive in VNT and ELISA until 6 dpi. These results suggest 
that the antibody titers of the vaccinated group appeared 
seropositive earlier, and the mean antibody titers were 
higher 6–10 dpi in VNT and C-ELISA compared to 
those of the unvaccinated group. The serological studies 
revealed a positive relationship between the VNT and 
C-ELISA in the vaccine-treated group, with a coinci-
dence rate of 91.7% (22/24) (data not shown).
Viral antigens in PBMCs from the vaccinated group 
were detected 4 and 8 dpi; however, compared to the 
unvaccinated group, the mean viral load in PBMCs was 
much less during the experiment (Table 3). In both vacci-
nated and unvaccinated group, viral RNA was low in cen-
tral nervous tissues (Table 4). In addition, there were no 
histopathological changes in the CNS of the vaccinated 
and unvaccinated group.
Discussion
There was a previous study on experimental AKAV 
infection of pregnant cows and calves with genogroup 
II strains, resulting in congenital abnormalities and 
nonpurulent encephalomyelitis, respectively [22, 23, 24]. 
Although some studies regarding AKAV infection were 
reported, the precise mechanisms of AKAV infection 
causing neuropathology in animals after birth still remain 
to be determined. In the present study, we investigated 
the neuropathogenicity of a newly isolated AKAV-7 from 
cows by inoculating them via IC, IS, IV and SC routes. To 
evaluate neurovirulence, neuroinvasiveness and antibody 
production, several tests such as clinical, histopatho-
logical, serological analysis [25] and real-time PCR were 
performed.
A serosurveillance study in Korea demonstrated that 
seropositive rates for AKAV were 14.2% in aborted calves 
before a massive outbreak in 2010 [26]. In 2010, the VNT 
titers were higher than 4 (log2) in most affected cows. 
Among the tested sera, the highest VNT titers were 12 
(log2) [27]. Likewise, the VNT titers of all cows in the 
present study showed seropositivity after 12 dpi except 
in the IC inoculation group. The highest VNT titers were 
10 (log2) at 12 dpi in the IV group. In contrast, only two 
VNT titers and one ELISA titer of samples were sero-
positive in the IC group. The few seropositive samples 
from the IC group could be related to severe neurological 
signs and mortality compared to other groups. We spec-
ulate that direct injection of AKAV into the brain can 
not efficiently stimulate immunity since brain is immune 
privileged organ and subsequently fails to control virus 
replication in the brain.
Akabane virus strain distribution in the CNS and 
PBMCs was detected by real-time PCR. Based on the 
viral RNA levels in PBMCs, these was a tendency to 
show two peaks after infection, although all results in 
the groups varied according to inoculation routes. Even 
when the virus was inoculated in the frontal lobe of 
the cerebrum in the IC group, the viral antigens were 
detected primarily in the brainstem. Interestingly, the 
results from some cows in the IC group showed that viral 
spread reached the lumbar spinal cord. In addition, viral 
RNA in the IS group was mostly detected in the injection 
region (thoracolumbar region) and organs of the immune 
system 7 dpi in addition to the cervical spinal cord and 
mid brain 21 dpi. Several studies have reported viral anti-
gens of the Iriki strain were detected in the brain or/and 
spinal cord of mice and two calves after IC inoculation 
[15, 28]. Likewise, we found that viral antigens were dis-
tributed widely throughout the CNS of cows after IC and 
IS inoculation.
The cows infected with AKAV in 2010 showed simi-
lar clinical signs to those infected with the Iriki strain, 
including locomotor ataxia, astasia and hind or forelimb 
paralysis. Histopathologically, the infected cows showed 
encephalomyelitis with meningitis, PVC and gliosis 
[17]. Histopathological examination of the present study 
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Figure 4 Nonsuppurative encephalomyelitis in central nervous tissues of the IC, IS and SC groups with AKAV-7. A PVC (arrows) in the 
frontal lobe of the IC group 7 dpi, H&E. Original magnification, ×40. B Meningitis (arrows) in the frontal lobe of the IC group 7 dpi, H&E. Original 
magnification, ×40. C Meningitis (arrow) in the cerebellum of the IC group 7 dpi, H&E. Original magnification, ×40. D PVC (arrow) in the cervical spi‑
nal cord of the IC group 7 dpi, H&E. Original magnification, ×100. E PVC (arrow) in the mid brain of the IS group 21 dpi, H&E. Original magnification, 
×200. F PVC (arrow) in the lumbar spinal cord of the IS group 21 dpi, H&E. Original magnification, ×200. G PVC (arrow) in the medulla oblongata of 
the SC group 21 dpi, H&E. Original magnification, ×100. H PVC (arrow) in the cervical spinal cord of the SC group 21 dpi, H&E. Original magnifica‑
tion, ×100.
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Table 2 Incidence of histopathological lesions in the CNS of each group (n = 3) infected with AKAV-7
a Two of three cows died 9 dpi and one of three cows died 12 dpi after IC inoculation.
Different CNS area IC group IS group Unvaccinated IV group Vaccinated IV group SC group
7 dpi 21 dpia 7 dpi 21 dpi 21 dpi 21 dpi 21 dpi
Cerebrum 3/3 1/3 0/3 0/3 0/3 0/3 1/3
Cerebellum 2/3 0/3 0/3 0/3 0/3 0/3 0/3
Brain stem 2/3 2/3 0/3 1/3 0/3 0/3 1/3
Spinal cord 1/3 0/3 0/3 1/3 0/3 0/3 1/3
Figure 5 Immunohistochemical characteristics in the central nervous tissues of cows in the IC and SC groups with AKAV-7. A Detec‑
tion of AKAV‑7 antigens within the cytoplasm of neurons (arrow) and axons in the mid brain of the IC group 7 dpi, IHC. Original magnification, 
×200. B Detection of AKAV‑7 antigens (arrow) in the mid brain of the IC group 7 dpi, IHC. Original magnification, ×400. C Detection of AKAV‑7 
antigens in the frontal lobe of the IC group 21 dpi, IHC. Original magnification, ×200. D Detection of AKAV‑7 antigens (arrows) in the parietal lobe 
of the IC group 21 dpi, IHC. Original magnification, ×400. E Detection of AKAV‑7 antigens within the cytoplasm of neurons (arrow) and axons in 
the pons of the SC group 21 dpi, IHC. Original magnification, ×200. F Detection of AKAV‑7 antigens (arrow) in the pons of the SC group 21 dpi, IHC. 
Original magnification, ×200.
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confirmed encephalomyelitis in the CNS of cows and the 
variation of pathogenicity depending on the inoculation 
route after AKAV-7 infection. In the present study, five 
of six and two of six cows showed clinical signs after IC 
and IS injection, respectively. Furthermore, three of six 
cows in the IC group died before sacrifice. These results 
are comparable to a previous study that revealed severe 
encephalitis appeared in calves after IC inoculation 
with the Iriki strain [15]. Histopathological examination 
revealed that IC infection is more neurovirulent than 
other routes and that cows died from nonsuppurative 
encephalomyelitis after IC inoculation. Several reasons 
for this could exist. First, the virus was injected directly 
into the CNS (frontal lobe of cerebrum) of the IC group, 
leading direct viral infection in the neuron and subse-
quently causing severe neurological symptom. Second, 
low titers of neutralizing antibody in the IC group were 
detected. No marked clinical signs or histopathological 
changes were observed after IV infection.
As genogroup II strains were primarily isolated from 
Korea before 2010 [29], these strains were used as vaccine 
strains. To verify the effectiveness of the current AKAV 
vaccine for preventing AKAV-7 classified into genogroup 
Ia, cows were vaccinated 3 weeks before IV infection and 
compared to the IV group. There were significant differ-
ences in antibody titers of VNT 6 dpi and ELISA 4 and 6 
dpi between the vaccinated and IV groups. Seroconversion 
of the vaccinated group occurred earlier, 6 dpi, compared 
to the IV group. Likewise, faster developing antibody titers 
could be contributed to protection from AKAV by sup-
pressing virus replication and distribution. Such idea can 
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Figure 6 Efficacy assessment of the AKAV vaccine against AKAV-7 IV infection. In VNT, animals were considered AKAV‑seropositive when 
the neutralizing antibody titer (log2) rose above a threshold of 2 (reference line). In C‑ELISA results, P.I. values greater than 70% are considered 
positive for AKAV antibodies (reference line). Empty dots indicate the vaccinated group before IV infection and filled dots indicate the IV group 
without vaccination. A Neutralizing antibody titers resulting from VNT in the vaccinated group. B AKAV‑7 antibodies detected by C‑ELISA. Data are 
presented as mean ± SEM per group; *p < 0.05; **p < 0.01; ***p < 0.001.
Table 3 Results of quantitative real-time PCR for the AKAV 
antigen in PBMCs
Data are presented as mean ± SEM per group.
Days post infection Unvaccinated IV group Vaccinated IV group
0 0 0
2 76 580.2 ± 7651.9 6.4 ± 2.4
4 1199.9 ± 1191.5 238.5 ± 221.2
6 2464.7 ± 2459.4 133.9 ± 129.8
8 2044.7 ± 2036.4 440.0 ± 433.0
10 1629.5 ± 1622.6 16.4 ± 12.8
12 2530.5 ± 2518.8 36.4 ± 20.2
14 1632.1 ± 1628.6 10.7 ± 4.0
Table 4 Results of quantitative real-time PCR for the AKAV 
antigen in various tissues
Data are presented as mean ± SEM per group.
Tissues Unvaccinated IV group Vaccinated IV group
Frontal lobe 9.8 ± 6.0 2.4 ± 2.4
Parietal lobe 6.3 ± 5.2 2.2 ± 2.2
Occipital lobe 3.2 ± 2.7 2.4 ± 2.4
Cerebellum 11.8 ± 9.2 2.9 ± 2.9
Mid brain 26.6 ± 23.4 4.2 ± 4.2
Pons 40.6 ± 26.0 4.5 ± 4.5
Medulla oblongata 4.2 ± 2.1 7.5 ± 7.5
Cervical spinal cord 15.5 ± 9.5 9.1 ± 9.1
Thoracic spinal cord 22.1 ± 15.2 7.1 ± 7.1
Lumbar spinal cord 33.8 ± 29.7 3.3 ± 3.3
Spleen 430.6 ± 358.2 2007.0 ± 1968.3
Lymph node 14.7 ± 7.9 1758.9 ± 1750.0
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explain that the viral load of the vaccinated group showed 
a low level in CNS compared to unvaccinated group. 
Taken together, these data suggest that the present AKAV 
vaccine in Korea is likely to be protective against AKAV-7.
To study the neuropathogenicity of AKAV-7, intrader-
mal (ID), IV and SC infection were performed to mimic 
the infection mechanism of arbovirus. Cows in the ID 
group (data not shown) showed no significant clinical 
signs or histopathological changes. This could be because 
ID inoculation with the exact volume to skin was limited 
in cows. Although the IV and SC groups showed no obvi-
ous clinical signs, severe encephalomyelitis was identi-
fied in the SC group on histopathological examination. 
Furthermore, more viral antigens were detected mostly 
in the brain stem and cervical spinal cord compared to 
other organs of SC groups. Therefore, viral encephalo-
myelitis in the SC group was confirmed by detecting viral 
antigens and on histopathology even though there were 
no clinical signs. From this perspective, SC inoculation 
might be more appropriate for performing experimental 
AKAV-7 infection in cows than IV inoculation. Although 
there is no evidence why SC group showed encephalitis, 
but IV group did not, we speculate that some antigen 
presenting cells in the subcutaneous area might con-
tribute to replication and delivery of virus into the CNS. 
Further study will be necessary to elucidate the detailed 
neuropathogenic mechanism of AKAV-7.
It is important to consider the differences and similari-
ties between infection with artificial routes (the present 
study) and natural infections. Based on previous study 
regarding outbreak in Korea in 2010, around 500 cat-
tle with neurological signs in more than 100 farms were 
reported [17]. Serological investigation of all cattle from 
the outbreak farms showed that over 70% of the cattle 
had AKAV specific antibodies. Such information clearly 
indicates that natural AKAV infection did not always 
induce encephalomyelitis in all infected cattle presum-
ably by natural barriers and host protective immunity. 
Sporadic outbreak of encephalomyelitis can explain why 
not all of the infected cattle with limited numbers via dif-
ferent routes showed clinical signs and neuropathology, 
and why data variations commonly occur in the same 
experimental group of our study.
In summary, this study demonstrated the neuropatho-
genicity of AKAV-7 inoculated via IC, IS and SC routes, 
which caused encephalomyelitis. Moreover, the current 
AKAV vaccine in Korea is considered to have partial pro-
tective effects against AKAV-7.
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